VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BCLI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BCLIBrainstorm Cell Therapeutics Inc.
$1.23$14M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBCLIQuarterly Financials

Brainstorm Cell Therapeutics Inc. (BCLI) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Brainstorm Cell Therapeutics Inc. (BCLI) quarterly income statement — complete revenue, gross profit & net income history

BCLI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue000000000343K0000000000
Revenue Growth %------100%--------------
Cost of Goods Sold37K48K0052K53K59K64K64K66K65K0070K00070K67K0
COGS % of Revenue---------19.24%----------
Gross Profit-37K-48K00-52K-53K-59K-64K-64K277K-65K00-70K000-70K-67K0
Gross Margin %---------80.76%----------
Gross Profit Growth %28.85%9.43%100%100%18.75%-119.13%9.23%--495.71%---0%100%-----
Operating Expenses2.01M2.2M2.05M2.57M3.09M3.19M3.05M2.98M2.47M4.74M6.04M5.45M5.15M4.92M6.84M7.59M5.47M6.21M5.28M6.12M
OpEx % of Revenue---------1381.34%----------
Selling, General & Admin1.28M-4.39M1.15M1.45M1.78M1.47M2M2.06M1.51M3.11M2.71M2.65M2.23M2.46M3.06M2.48M2.86M2.54M1.66M2.52M
SG&A % of Revenue---------905.54%----------
Research & Development725K-3.32M899K1.12M1.3M1.72M1.04M922K897K1.7M3.33M2.79M2.92M2.45M3.78M5.11M2.62M3.68M3.62M3.6M
R&D % of Revenue---------495.04%----------
Other Operating Expenses01000K00000064K-66K0000000000
Operating Income-2.05M-2.24M-2.05M-2.57M-3.09M-3.19M-3.05M-2.98M-2.47M-4.8M-6.04M-5.45M-5.15M-4.92M-6.84M-7.59M-5.47M-6.21M-5.28M-6.12M
Operating Margin %----------1400.58%----------
Operating Income Growth %33.77%29.63%32.84%13.72%-24.86%33.62%49.49%45.27%51.97%2.26%11.78%28.22%5.92%20.88%-29.64%-24.02%20.98%45.94%-17.66%17.28%
EBITDA-2.01M-2.2M-2M-2.52M-3.04M-3.14M-2.99M-2.92M-2.41M-4.74M-5.97M-5.38M-5.08M-4.84M-6.77M-7.52M-5.4M-6.14M-5.21M-6.06M
EBITDA Margin %----------1381.34%----------
EBITDA Growth %33.85%29.97%33.12%13.57%-26.02%33.81%49.93%45.78%52.6%2.21%11.83%28.43%5.87%21.12%-29.96%-24.11%21.36%46.25%-17.63%17.56%
D&A (Non-Cash Add-back)37K48K48K51K52K53K59K64K64K66K65K67K67K70K70K71K74K70K67K62K
EBIT-2.05M-2.24M-2.05M-2.57M-3.09M-3.19M-3.05M-2.98M-2.47M-5.58M-6.04M-5.45M-5.15M-4.92M-6.84M-7.59M-5.47M-6.21M-5.28M-6.12M
Net Interest Income-81K284K0-330K46K-66K-54K30K13K-184.12K-121K120K92K-103K-17K550K115K22K-59K-148K
Interest Income0-46K0046K0030K13K-92.12K0120K92K00550K115K22K00
Interest Expense81K-330K0330K066K54K0092K121K00103K17K00059K148K
Other Income/Expense-81K-190K-59K-330K225K216K340K441K-927K-774K4.81M120K92K-103K-17K550K115K22K-59K-148K
Pretax Income-2.13M-2.43M-2.11M-2.9M-2.86M-2.97M-2.71M-2.54M-3.4M-5.58M-1.23M-5.33M-5.06M-5.02M-6.86M-7.04M-5.36M-6.19M-5.34M-6.27M
Pretax Margin %----------1626.24%----------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-2.13M-2.43M-2.11M-2.9M-2.86M-2.97M-2.71M-2.54M-3.4M-5.58M-1.23M-5.33M-5.06M-5.02M-6.86M-7.04M-5.36M-6.19M-5.34M-6.27M
Net Margin %----------1626.24%----------
Net Income Growth %25.73%18.13%22.23%-14.25%15.79%46.7%-120.88%52.32%32.77%-11.16%82.12%24.31%5.62%18.93%-28.52%-12.31%19.54%47.61%-18.89%15.21%
Net Income (Continuing)-2.13M-2.43M-2.11M-2.9M-2.86M-2.97M-2.71M-2.54M-3.4M-5.58M-1.23M-5.33M-5.06M-5.02M-6.86M-7.04M-5.36M-6.19M-5.34M-6.27M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.19-0.22-0.19-0.34-0.45-0.52-0.51-0.54-0.79-1.66-0.42-1.95-2.10-0.14-2.85-2.85-2.25-0.17-2.25-2.55
EPS Growth %57.78%57.69%62.75%37.04%43.04%68.67%-21.43%72.31%62.38%-1085.71%85.26%31.58%6.67%17.65%-26.67%-11.76%21.05%48.48%-7.14%32%
EPS (Basic)-0.19-0.22-0.19-0.34-0.45-0.52-0.51-0.54-0.79-1.66-0.42-1.95-0.13-0.14-2.85-2.85-2.25-0.17-2.25-2.55
Diluted Shares Outstanding11.03M9.27M11.01M8.62M6.34M5.71M5.31M4.75M4.32M3.36M2.95M2.65M2.45M2.44M2.43M2.43M2.43M2.42M2.42M2.42M
Basic Shares Outstanding11.03M9.27M11.01M8.62M6.34M5.71M5.31M4.75M4.32M3.36M2.95M2.65M2.45M2.44M2.43M2.43M2.43M2.42M2.42M2.42M
Dividend Payout Ratio--------------------